Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Insulet Corporation (PODD)

318.96   2.08 (0.66%) 03-31 16:00
Open: 318.78 Pre. Close: 316.88
High: 324.1797 Low: 318.31
Volume: 882,088 Market Cap: 22,181(M)

Technical analysis

as of: 2023-03-31 4:21:22 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 381.63     One year: 445.74
Support: Support1: 291.09    Support2: 269.05
Resistance: Resistance1: 326.73    Resistance2: 381.63
Pivot: 313.44
Moving Average: MA(5): 314.99     MA(20): 306.41
MA(100): 297.22     MA(250): 261.83
MACD: MACD(12,26): 6.3     Signal(9): 5.8
Stochastic oscillator: %K(14,3): 78.7     %D(3): 77.4
RSI: RSI(14): 60.6
52-week: High: 326.73  Low: 181
Average Vol(K): 3-Month: 841 (K)  10-Days: 624 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ PODD ] has closed below upper band by 23.3%. Bollinger Bands are 42.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 324.57 - 325.82 325.82 - 327.07
Low: 315 - 316.51 316.51 - 318.02
Close: 316.56 - 318.84 318.84 - 321.12

Company Description

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Headline News

Sat, 01 Apr 2023
Here are the 20 best performing stocks of March — and the 20 worst - Morningstar

Fri, 31 Mar 2023
DexCom Inc. stock outperforms market on strong trading day - MarketWatch

Thu, 30 Mar 2023
Insulet to Announce First Quarter 2023 Financial Results on May 4 ... - Business Wire

Tue, 28 Mar 2023
Insulet (PODD) Benefits From Omnipod 5 Launch, Expansion - Nasdaq

Tue, 21 Mar 2023
Guru Fundamental Report for PODD - Nasdaq

Sun, 19 Mar 2023
Should You Invest in Insulet Corporation (PODD)? - Yahoo Finance

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 69 (M)
Shares Float 69 (M)
% Held by Insiders 0.4 (%)
% Held by Institutions 104.6 (%)
Shares Short 2,210 (K)
Shares Short P.Month 2,140 (K)

Stock Financials

EPS 0.1
EPS Est Next Qtl -0.11
EPS Est This Year -0.51
EPS Est Next Year -0.24
Book Value (p.s.) 9.14
Profit Margin (%) 1.3
Operating Margin (%) 5.1
Return on Assets (ttm) 1.9
Return on Equity (ttm) 3.6
Qtrly Rev. Growth 23.7
Gross Profit (p.s.) 10.82
Sales Per Share 17.85
EBITDA (p.s.) 1.8
Qtrly Earnings Growth 0
Operating Cash Flow 43 (M)
Levered Free Cash Flow -42 (M)

Stock Valuations

PE Ratio 3189.59
PEG Ratio 25.3
Price to Book value 34.89
Price to Sales 17.86
Price to Cash Flow 517.56

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.